0001104659-21-075782.txt : 20210602
0001104659-21-075782.hdr.sgml : 20210602
20210602163228
ACCESSION NUMBER: 0001104659-21-075782
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210528
FILED AS OF DATE: 20210602
DATE AS OF CHANGE: 20210602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wedell-Wedellsborg Johan
CENTRAL INDEX KEY: 0001753185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 21989579
MAIL ADDRESS:
STREET 1: RUNGSTED STRANDVEJ 113
CITY: RUNGSTED KYST
STATE: G7
ZIP: 2960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
tm2118093-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-05-28
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001753185
Wedell-Wedellsborg Johan
C/O WECO GROUP A/S
RUNGSTED STRANDVEJ 113
RUNGSTED KYST
G7
2960
DENMARK
1
0
0
0
Common Stock
2021-05-28
4
S
0
25000
36.3390
D
4453465
I
By WG Biotech ApS
Common Stock
2021-06-01
4
S
0
6864
35.5730
D
4446601
I
By WG Biotech ApS
This transaction was executed in multiple trades at prices ranging from $35.69 to $37.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $35.50 to $35.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.
/s/ Johan Wedell-Wedellsborg
2021-06-02